Memorial Sloan Kettering Cancer Center: Gliosarcoma trials
The registry lists 10 Gliosarcoma studies with Memorial Sloan Kettering Cancer Center as lead sponsor. 1 are open to participants now and 3 have results posted.
Phase 1 6Phase 2 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Study of ABBV-637 or ABBV-155 With ERAS-801 for People With GlioblastomaRecruitingNCT06934889Phase 1
- Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant GliomaCompletedNCT00498927Phase 2Results posted
- Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal CancerCompletedNCT00445965Phase 2Results posted
- Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate CancerCompletedNCT00085566Phase 1/2Results posted
- Immunotoxin Therapy Before and After Surgery in Treating Patients With Recurrent Malignant GliomaCompletedNCT00036972Phase 1
- Taurolidine in Treating Patients With Recurrent or Progressive GliomaCompletedNCT00022360Phase 1
- Motexafin Gadolinium Plus Radiation Therapy to the Brain in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00022256Phase 2
- Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant GliomaCompletedNCT00005637Phase 1
- Temozolomide in Treating Patients With Recurrent Malignant GliomaCompletedNCT00004113Phase 2
- Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal CancerCompletedNCT00003022Phase 1